Trellus Health®

From clinical trials to patient support programs, Trellus Elevate® bridges the gap between innovation and patient success. Our proven strategies help pharma and CRO partners deliver better results while putting patients first. Let’s elevate patient experiences together. Learn more: https://lnkd.in/ew4Tau7S. #TrellusHealth #PharmaSolutions #ClinicalTrials #PatientSupport #TrellusElevate

At Trellus Health®, we’re setting a new standard in patient support with Trellus Elevate®. Our resilience-driven program helps pharma partners empower patients, improve treatment adherence, and reduce unnecessary healthcare utilization. Whether you're advancing clinical trials or enhancing patient support programs, Trellus Elevate® offers a proven solution to elevate outcomes for patients and partners alike. Explore how we can partner to transform the patient experience: https://lnkd.in/ew4Tau7S. #TrellusHealth #PharmaSolutions #ClinicalTrials #PatientSupport #TrellusElevate

On March 2, our co-founder, Laurie Keefer, PhD, will speak at Canadian Digestive Diseases Week (CDDW) in Quebec City, tackling the complex challenges of food intolerance and ARFID (Avoidant/Restrictive Food Intake Disorder).   For so many, these issues can feel isolating, but they don’t have to be. At Trellus Health®, we help those living with IBD reclaim their lives through resilience-based support that addresses both the mind and body. It’s not just about managing symptoms—it’s about finding freedom. Learn more at www.trellushealth.com.  #Thrivein25 #Resilience #ChronicConditionManagement #TrellusHealth #TrellusElevate

That’s a wrap on an inspiring week at the European Crohn’s and Colitis Organisation Congress in Berlin! Our CEO and Co-founder, Marla Dubinsky, led a powerful session, "Navigating the Patient Journey: A Personal Conversation on Living with IBD." She shared heartfelt insights on the realities of IBD and how innovation is reshaping the path forward.   At Trellus Elevate®, we believe no one should navigate IBD alone. By integrating mental health, resilience, and IBD-specific support, we’re transforming the way IBD is managed. Learn more at www.trellushealth.com.   #Thrivein25 #Resilience #ChronicConditionManagement #TrellusHealth #TrellusElevate  

That’s a wrap on an incredible week at the 2025 J.P. Morgan Healthcare Conference! Trellus Health® was thrilled to connect with visionary healthcare leaders and investors who share our commitment to transforming chronic condition management. It was inspiring to showcase Trellus Elevate®, our resilience-driven digital solution, and discuss how we're improving outcomes, reducing costs, and enhancing quality of life. As we carry this momentum throughout 2025, we’re excited to continue building partnerships that make a real impact. Missed us at JPM? It’s not too late to explore how Trellus Elevate® can transform chronic condition management for your organization. Request a demo to learn more: https://lnkd.in/ermVSgE3 #JPM2025 #TrellusElevate #TrellusHealth #IBD #ChronicConditionManagement Kathleen A. Williams Joy Bessenger Marla Dubinsky Kevin Murphy

 We are proud to announce Kathleen A. Williams as Chief Innovation Officer at Trellus Health®! This newly created role highlights our unwavering commitment to transforming chronic condition management. With over 25 years in health innovation, Kathleen will drive our product and account management strategies, ensuring resilience-based, personalized support that empowers individuals with complex chronic conditions. Please join us in celebrating Kathleen's leadership as she helps shape a healthier future and strengthens Trellus Health's impact in transforming lives.   https://lnkd.in/eCx642VU   #Thrivein25 #TrellusElevate #TrellusHealth #IBD #ChronicConditionManagement

We’re proud to announce our collaboration with Johnson & Johnson to pilot the Trellus Elevate® platform in the U.S., bringing holistic support to patients with moderately to severely active inflammatory bowel disease (IBD). Through this one-year partnership, eligible patients prescribed a Johnson & Johnson therapy will gain access to Trellus Elevate®, empowering them with the tools and confidence to navigate the emotional and physical challenges of their condition and take control of their health journey. As Marla Dubinsky, CEO of Trellus Health, shares: "We have reached a therapeutic ceiling with many existing treatments for IBD, and it is only by addressing both the mind and body that we can break through that barrier."   We’re just getting started—more details about the official launch are coming soon. Stay tuned!    Read the full RNS here: https://lnkd.in/edaUN4En #Thrivein25 #TrellusElevate #TrellusHealth #IBD #ChronicConditionManagement

In just a few days, Trellus Health® will join innovators, investors, and leaders at the 2025 J.P. Morgan Healthcare Conference, starting January 13. We’re excited to showcase Trellus Elevate® —our resilience-driven solution that’s revolutionizing chronic condition management. With a focus on improving patient outcomes, reducing costs, and enhancing quality of life, we’re looking forward to sparking meaningful conversations and collaborations. Are you attending? Let’s connect and discuss how we can drive innovation together. Contact Joy Bessenger, CFO of Trellus Health®, at info@trellushealth.com to schedule a meeting. #JPM2025 #TrellusElevate #TrellusHealth #IBD #ChronicConditionManagement

We’re excited to share that Marla Dubinsky will be speaking on the JPM panel: "The Digital Health Evolution: Current Investment Landscape and What’s Next" on January 15th, 10:00 – 10:40 AM PT. Marla will be sharing how Trellus Health® is transforming the way complex chronic conditions are managed—putting people first, improving outcomes, and reducing costs. Curious why our approach works? See how we’re innovating with science-backed support that truly makes a difference. Learn more and schedule a demo today: https://lnkd.in/e37RKGy3. #JPM2025 #TrellusElevate #TrellusHealth #IBD #ChronicConditionManagement Goodwin

The 2025 J.P. Morgan Healthcare Conference kicks off next week! We’re excited to connect with life sciences and healthcare investors and pharma partners who share our passion for transforming chronic condition management. Our focus remains clear: better outcomes, reduced costs, and enhanced quality of life through resilience-driven digital health. Let’s make it happen together! Schedule a meeting with Joy Bessenger, CFO of Trellus Health®, at info@trellushealth.com. #JPM2025 #TrellusElevate #TrellusHealth #IBD #ChronicConditionManagement Goodwin